Funding Opportunities

Purpose There remains a critical shortage of organs to meet the needs of individuals with end-stage organ failure who can benefit from an organ transplant. As of March 2024, there were approximately 89,000 patients on the organ transplant wait list waiting for a kidney and 9,800 patients waiting for a liver. Kidneys and livers combined represent approximately 96 percent of the organ needs among patients on the organ transplant wait list. People can donate a kidney, part of their liver, and certain other organs while alive. In 2023, nearly 7,000 people donated an organ while alive, including nearly 6,300 living kidney donors and 660 living liver donors. HRSA’s Living Organ Donation Reimbursement Program (LODRP) provides financial assistance to people who wish to be living organ donors, but who might otherwise not be able to donate due to financial hardship. The program reimburses qualified expenses related to eligible living donors’ medical evaluations, surgeries, and follow-up visits, including travel, lost wages, child and elder care, and other expenses, as outlined in its notice about reimbursement of travel and subsistence expenses toward living organ donation program eligibility. From October 2007 to August 2024, the program (currently operated by the National Living Donor Assistance Center) received more than 18,000 applications for reimbursement by prospective living donors, approving nearly 89 percent of them. During this timeframe, NLDAC facilitated over 10,000 living organ donations. In 2023, the median household income for prospective living donor applicants to LODRP was approximately $66,000, which is 18 percent below the national median income level of $80,600. While great progress has been made in expanding access to living organ transplants through HRSA’s LODRP program, we recognize that more needs to be done. For example, even though more than 60 percent of people on the national transplant waiting list are from a minority group, only approximately 40 percent of patients from a minority group received a living organ transplant through the program. To expand awareness and access to the LODRP, particularly among medically underserved communities, HRSA created the PE-LODRP in FY2025. The recipient of this award will work closely with HRSA and the LODRP award recipient to promote the program and to provide targeted outreach and education to communities historically underserved by the program.

Eligibility Information Not Available

HRSA-25-041

N/A

UK9

93.912

Open

HRSA-25-097

N/A

H4B

93.253

Open

HRSA-25-020

N/A

U0A

93.110

Open

HRSA-25-021

N/A

UM4

93.877

Open

Cooperative Agreement True
Guidance Availablility Yes

Purpose The Maternal and Child Health Bureau Research Consortium Program (MCHB RCP) creates a national group of researchers to study maternal and child health (MCH). In the past, MCHB funded research networks, single investigator innovation studies, and field-initiated research studies. The MCHB RCP merges these programs into one. In FY25, this NOFO replaces the Research Network program, including the Autism Intervention Research Network on Behavioral Health (AIR-B) and the Autism Intervention Research Network on Physical Health (AIR-P). Parent-reported data from the 2022 National Survey of Children’s Health (NSCH) documented that 3.6% of children ages 3-17 years had a current diagnosis of autism, representing nearly 2.2 million children and adolescents.[5] Autistic children have higher rates of co-occurring mental and behavioral health conditions compared to children without autism, and access to adequate health care is a significant challenge for children with autism.[6] Of particular concern are the disparities in timing of diagnosis, access to services, and quality of care.[7] Research about effective and scalable interventions and services is needed to address the diverse and complex needs of autistic children and their families, with a focus on underserved and vulnerable populations. Autism RC recipients will develop research-practice partnerships[8] with community organizations, people and families with lived experience,[9] and MCHB programs. Through these partnerships, you will identify best practices for maximizing the impact of research. Research Centers will improve systems of care by translating and implementing evidence-based interventions to improve physical and behavioral health of children with autism and other DD across the lifespan. The Autism RC will advance the evidence base on effective interventions, services, supports, and systems for children and adolescents with autism and other DD. Priority areas for the Autism RC were selected based on alignment with MCHB’s strategic priorities including the Blueprint for Change,[10] and the 2021-2023 IACC Strategic Plan.[11] Each application under this NOFO will focus on one of the following categories. We anticipate funding up to 2 awards in each category. You are expected to focus on one or more of the priority topics listed within your chosen category (if applicable). To respond to this NOFO, you must focus on children or adolescents with autism and other DD.

Eligibility Information Not Available

HRSA Electronic Handbooks

User Navigation

Main Navigation

Sub Navigation

Funding Opportunities - List

Search Filters:

Basic Search Parameters

Advanced Search Parameters

Display Options

Footer Information

Tools Panel